-
Potential targeted therapy found for newly identified leukemia subtype with poor outcome
The MEF2D-rearranged subtype of acute lymphoblastic leukemia (ALL) is linked to poor outcomes. Now a possible targeted therapy has been identified.
-
Mobile health app to help sickle cell patients
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
-
Researchers uncover genetic hallmarks of ALL subtype
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
-
Researchers reveal genomic landscape of CBF-AML
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
-
Chemo drug impairs multitasking for some survivors
Higher blood levels of methotrexate during treatment of childhood leukemia have been linked to diminished executive function in long-term survivors.
-
Patient safety benefits when hospitals provide feedback
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
From Promise, Winter 2017
More articles from this issue
-
The Best Day Possible
The St. Jude Quality of Life for All team goes above and beyond to improve patients’ psychosocial, emotional, and symptom concerns.
-
Handwriting: Back to Basics
St. Jude staff members help children learn, or re-learn, the art of handwriting.
-
Young Readers are STARRs
The STARR program provides academic assistance for children with sickle cell disease and hemophilia.
-
Patients Pay it Forward
St. Jude Child Life unites five patients and inspires them to help one another persevere.
-
The 2017 Prom Challenge
Teenagers unite to party with a purpose.
-
Land of Opportunity
A gift of property supports the hospital’s Genomes for Kids clinical trial.
-
Snip of DNA Spells Hope
St. Jude scientists use gene editing in quest to help children with sickle cell disease.
-
Protection from Infection
There’s ‘clean,’ and then there’s ‘St. Jude clean.’ Learn some of the tactics St. Jude uses to keep infection rates low.
-
Sabrina Soto Answers the Question, 'What's Really Important?'
Lifestyle expert Sabrina Soto explains how a focus on family makes St. Jude extra special.
-
Already a Winner
A long-term leukemia survivor runs to help the hospital that saved his life.